Apil patent expiration

1. Actonel patent expiration

ACTONEL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5583122 APIL Pharmaceutical compositions containing geminal diphosphonates
Dec, 2013

(10 years ago)

US5583122

(Pediatric)

APIL Pharmaceutical compositions containing geminal diphosphonates
Jun, 2014

(10 years ago)

US6165513 APIL Film-coated tablet for improved upper gastrointestinal tract safety
Jun, 2018

(6 years ago)

US6015801 APIL Method for inhibiting bone resorption
Jul, 2018

(6 years ago)

US5994329 APIL Method for inhibiting bone resorption
Jul, 2018

(6 years ago)

US6432932 APIL Method for inhibiting bone resorption
Jul, 2018

(6 years ago)

US6465443 APIL Method for inhibiting bone resorption
Aug, 2018

(5 years ago)

US6165513

(Pediatric)

APIL Film-coated tablet for improved upper gastrointestinal tract safety
Dec, 2018

(5 years ago)

US6432932

(Pediatric)

APIL Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

US5994329

(Pediatric)

APIL Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

US6015801

(Pediatric)

APIL Method for inhibiting bone resorption
Jan, 2019

(5 years ago)

US6465443

(Pediatric)

APIL Method for inhibiting bone resorption
Feb, 2019

(5 years ago)

US7192938 APIL Method of treatment using bisphosphonic acid
May, 2023

(1 year, 2 months ago)

US7718634 APIL Method of treatment using bisphosphonic acid
May, 2023

(1 year, 2 months ago)

US7192938

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(8 months ago)

US7718634

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(8 months ago)




Drug Exclusivity Drug Exclusivity Expiration
M(M-61) Jul 23, 2012
Pediatric Exclusivity(PED) Jan 23, 2013

Drugs and Companies using RISEDRONATE SODIUM ingredient

Market Authorisation Date: 14 April, 2000

Treatment: Method of treating paget's disease using actonel; Prevention and treatment of osteoporosis; 35 mg orally once a week for prevention of osteoporosis in postmenopausal women; 35 mg orally once a week fo...

Dosage: TABLET

How can I launch a generic of ACTONEL before it's drug patent expiration?
More Information on Dosage

ACTONEL family patents

Family Patents

2. Asacol patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5541170 APIL Orally administrable pharmaceutical compositions
Jul, 2013

(10 years ago)

US5541171 APIL Orally administrable pharmaceutical composition
Jul, 2013

(10 years ago)




Drugs and Companies using MESALAMINE ingredient

Market Authorisation Date: 31 January, 1992

Treatment: Treatment of ulcerative colitis

Dosage: TABLET, DELAYED RELEASE

How can I launch a generic of ASACOL before it's drug patent expiration?
More Information on Dosage

ASACOL family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Atelvia patent expiration

ATELVIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5583122 APIL Pharmaceutical compositions containing geminal diphosphonates
Dec, 2013

(10 years ago)

US5622721 APIL Dosage forms of risedronate
Apr, 2014

(10 years ago)

US5583122

(Pediatric)

APIL Pharmaceutical compositions containing geminal diphosphonates
Jun, 2014

(10 years ago)

US8246989 APIL Dosage forms of bisphosphonates
Jan, 2026

(1 year, 5 months from now)

US7645459 APIL Dosage forms of bisphosphonates
Jan, 2028

(3 years from now)

US7645460 APIL Dosage forms of risedronate
Jan, 2028

(3 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Oct 08, 2013

Drugs and Companies using RISEDRONATE SODIUM ingredient

Market Authorisation Date: 08 October, 2010

Treatment: Treatment of osteoporosis in postmenopausal women

Dosage: TABLET, DELAYED RELEASE

How can I launch a generic of ATELVIA before it's drug patent expiration?
More Information on Dosage

ATELVIA family patents

Family Patents

4. Femcon Fe patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6667050 APIL Chewable oral contraceptive
Apr, 2019

(5 years ago)




Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ingredient

Market Authorisation Date: 14 November, 2003

Treatment: Prevention of pregnancy

Dosage: TABLET

More Information on Dosage

FEMCON FE family patents

Family Patents

5. Femtrace patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7799771 APIL Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Dec, 2021

(2 years ago)

US6962908 APIL Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Dec, 2021

(2 years ago)

US7572779 APIL Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Oct, 2025

(1 year, 2 months from now)




Drugs and Companies using ESTRADIOL ACETATE ingredient

Market Authorisation Date: 20 August, 2004

Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause

Dosage: TABLET

More Information on Dosage

FEMTRACE family patents

Family Patents

6. Lo Loestrin Fe patent expiration

LO LOESTRIN FE IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5552394 APIL Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
Jul, 2014

(9 years ago)

US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(4 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 21, 2013

Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 21 October, 2010

Treatment: Lo loestrin fe is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET

How can I launch a generic of LO LOESTRIN FE before it's drug patent expiration?
More Information on Dosage

LO LOESTRIN FE family patents

Family Patents

7. Lo Minastrin Fe patent expiration

LO MINASTRIN FE IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5552394 APIL Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
Jul, 2014

(9 years ago)

US6667050 APIL Chewable oral contraceptive
Apr, 2019

(5 years ago)

US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(4 years from now)




Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 24 July, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET, CHEWABLE, TABLET

More Information on Dosage

LO MINASTRIN FE family patents

Family Patents

8. Minastrin 24 Fe patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5552394 APIL Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
Jul, 2014

(9 years ago)

US6667050 APIL Chewable oral contraceptive
Apr, 2019

(5 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) May 08, 2016

Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 08 May, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET

How can I launch a generic of MINASTRIN 24 FE before it's drug patent expiration?
More Information on Dosage

MINASTRIN 24 FE family patents

Family Patents

9. Taytulla patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5552394 APIL Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
Jul, 2014

(9 years ago)

US6652880 APIL Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
Mar, 2020

(4 years ago)




Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ACETATE ingredient

Market Authorisation Date: 19 April, 2013

Treatment: Prevention of pregnancy

Dosage: CAPSULE

More Information on Dosage

TAYTULLA family patents

Family Patents